Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years

OBJECTIVES: This study aimed to identify potential safety signals and adverse events following the primary Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccination series among children and adolescents aged 5 to 17 years in the Republic of Korea. METHODS: Adverse events reported through the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seontae, Heo, Yeseul, Seo, Soon-Young, Lim, Do Sang, Cho, Enhi, Lee, Yeon-Kyeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Disease Control and Prevention Agency 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633262/
https://www.ncbi.nlm.nih.gov/pubmed/36328243
http://dx.doi.org/10.24171/j.phrp.2022.0233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633262/
https://www.ncbi.nlm.nih.gov/pubmed/36328243
http://dx.doi.org/10.24171/j.phrp.2022.0233

Ejemplares similares